Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
OPERATING ACTIVITIES
Net Earnings	$ 18,892	$ 33,110
Adjustments to reconcile Net Earnings to Net Cash Provided by Operating Activities:
Depreciation	11,964	13,186
Amortization	1,368	1,812
Impairment of Long-Lived Assets	11,199	0
Deferred Income Taxes	(4,161)	3,136
Share-Based Compensation Expense	6,580	5,261
Allowance for Doubtful Accounts and Returns	1,426	1,248
Other, Net	(102)	(45)
Changes in Operating Assets and Liabilities:
Receivables	6,693	(6,077)
Inventories	(14,712)	(21,720)
Accounts Payable	(4,720)	5,879
Employee Compensation and Benefits	2,354	1,755
Other Current Liabilities	(872)	216
Income Taxes	(825)	137
Other Assets and Liabilities	(4,180)	(1,073)
Net Cash Provided by Operating Activities	30,904	36,825
INVESTING ACTIVITIES
Purchases of Property, Plant and Equipment	(14,597)	(13,476)
Proceeds from Disposals of Property, Plant and Equipment	257	235
Proceeds from Divestiture of Businesses	1,188	1,418
Increase in Restricted Cash	(319)	(12)
Net Cash Used in Investing Activities	(13,471)	(11,835)
FINANCING ACTIVITIES
Payments of Short-Term Debt	0	(1,500)
Payment of Long-Term Debt	(3,429)	(2,015)
Purchases of Common Stock	(39,123)	(13,609)
Proceeds from Issuance of Common Stock	981	1,650
Excess Tax Benefit on Stock Plans	707	1,620
Dividends Paid	(10,953)	(10,854)
Net Cash Used in Financing Activities	(51,817)	(24,708)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(1,771)	(1,482)
Net Decrease in Cash and Cash Equivalents	(36,155)	(1,200)
Cash and Cash Equivalents at Beginning of Period	92,962	80,984
Cash and Cash Equivalents at End of Period	56,807	79,784
Supplemental Disclosure of Cash Flow Information:
Cash Paid for Income Taxes	18,052	8,274
Cash Paid for Interest	886	1,107
Supplemental Non-cash Investing and Financing Activities:
Capital Expenditures in Accounts Payable	$ 721	$ 1,001